Archive
GLP-1
+6
May 29, 2026
•
10 min read
ADA Conference 2026 Preview
The Super Bowl Conference for diabetes and incretins!
GLP-1
+3
May 21, 2026
•
4 min read
Triumphant! Retatrutide matches bariatric surgery outcomes
Triumph 1 trial led to 19-30% weight loss depending on dose and time on trial.
GLP-1
+1
Apr 16, 2026
•
2 min read
ACHIEVEment Unlocked!
Orforglipron reduces the risk of cardiovascular events and all cause death in diabetic patients
GLP-1
+3
Mar 19, 2026
•
7 min read
Retatrutide TRANSCENDS diabetes in first phase 3 trial
A shift in what's possible for diabetes and obesity
GLP-1
+2
Mar 11, 2026
•
11 min read
More amylin updates & more tolerable drugs(finally)?
More early trial results from some new players in the obesity medicine space
GLP-1
+5
Dec 16, 2025
•
40 min read
GLP-1 and the kidneys
Incretins are changing the narrative of chronic kidney disease
